Lecithin-based novel cationic nanocarriers (LeciPlex) I: Fabrication, characterization and evaluation

Nanomedicine

Volumn 6, Issue 8, 2011, Pages 1309-1325

  Date, Abhijit A ^a   Srivastava, Deepika ^b   Nagarsenker, Mangal S ^a   Mulherkar, Rita ^b   Panicker, Lata ^c   Aswal, Vinod ^c   Hassan, Puthusserickal A ^c   Steiniger, Frank ^d   Thamm, Jana ^d   Fahr, Alfred ^d  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b TATA MEMORIAL HOSPITAL   (India)

^c BHABHA ATOMIC RESEARCH CENTRE   (India)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

cationic nanocarrier; CTAB; DDAB; lecithin; SANS; Transcutol; transfection

Indexed keywords

2 PYRROLIDINONE; CATION; CELECOXIB; CETRIMIDE; DIDODECYLDIMETHYLAMMONIUM BROMIDE; DIETHYLENE GLYCOL MONOETHYL ETHER; MELOXICAM; NANOCARRIER; NANOMATERIAL; PHOSPHATIDYLCHOLINE; PLASMID DNA; QUERCETIN; REPAGLINIDE; SOLVENT; SURFACTANT; TRICLOSAN;

AGAR GEL ELECTROPHORESIS; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOENCAPSULATION; NANOFABRICATION; NEUTRON SCATTERING; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

CELL LINE; DRUG CARRIERS; HUMANS; LECITHINS; NANOSTRUCTURES; NANOTECHNOLOGY; QUATERNARY AMMONIUM COMPOUNDS; TRANSFECTION;

EID: 79958272247     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.38     Document Type: Article

References (46)

1. Canty DJ, Zeisel SH. Lecithin and choline in human health and disease. Nutr. Rev. 52, 327-339 (1994).
2. Rowe RC, Sheskey PJ, Weller PJ. Lecithin. In: Handbook of Pharmaceutical Excipients (5th Edition), Pharmaceutical Press, NY, USA, 409-411 (2006).
3. Spernath A, Aserin A, Ziserman L, Danino D, Garti N. Phosphatidylcholine embedded microemulsions: physical properties and improved caco-2 cell permeability. J. Control. Release 119, 279-290 (2007).
4. Chen CC, Tsai TH, Huang ZR, Fang JY. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur. J. Pharm. Biopharm. 74, 474-482 (2010).
5. Varshosaz J, Minayian M, Moazen E. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. J. Liposome Res. 20, 115-123 (2010).
6. Sant VP, Nagarsenker MS, Rao SG, Gude RP. Enhancement of anti-metastatic activity of pentoxifylline by encapsulation in conventional liposomes and sterically stabilized liposomes in murine experimental B16F10 melanoma model. J. Pharm. Pharmacol. 52, 1461-1466 (2000).
7. Simberg D, Weisman S, Talmon Y, Barenholz Y. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit. Rev. Ther. Drug Carrier Syst. 21, 257-317 (2004).
8. Schuch G. EndoTAG-1. MediGene. Curr. Opin. Investig. Drugs 6, 1259-1265 (2005).
9. Kitagawa S, Kasamaki M. Enhanced delivery of retinoic acid to skin by cationic liposomes. Chem. Pharm. Bull. 54, 242-244 (2006).
10. Gershanik T, Benita S. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone. Pharm. Dev .Technol. 1, 147-157 (1996).
11. Gershanik T, Benzeno S, Benita S. Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm. Res. 15, 863-869 (1998).
12. Jain V, Prasad V, Jadhav P, Mishra PR. Preparation and performance evaluation of saquinavir laden cationic submicron emulsions. Drug Deliv. 16, 37-44 (2009).
13. Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Ravi Kumar MN. Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy. Pharm. Res. 23, 184-195 (2006).
14. Bala I, Bhardwaj V, Hariharan S, Kharade SV, Roy N, Ravi Kumar MN. Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration. J. Drug Target. 14, 27-34 (2006).
15. Bhardwaj V, Ankola DD, Gupta SC, Schneider M, Lehr CM, Kumar MN. PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat. Pharm. Res. 26, 2495-2503 (2009).
16. Liu D, Liu C, Zou W, Zhang N. Enhanced gastrointestinal absorption of N3-O-toluylfluorouracil by cationic solid lipid nanoparticles. J. Nanoparticle Res. 12, 975-984 (2010).
17. Peira E, Carlotti ME, Trotta C, Cavalli R, Trotta M. Positively charged microemulsions for topical application. Int. J. Pharm. 346, 119-123 (2008).
18. Swart HC, Du Preez JL, De Villiers MM, Ltter AP, Liebenberg W. Correlation between in vitro release from topical delivery vehicles and microbicidal activity of triclosan. Pharmazie 61, 35-40 (2006).
19. Redkar M, Hassan PA, Aswal V, Devarajan P. Onion phases of PEG-8 distearate. J. Pharm. Sci. 96, 2436-2445 (2007).
20. Cui Z, Qiu F, Sloat BR. Lecithin-based cationic nanoparticles as a potential DNA delivery system. Int. J. Pharm. 313, 206-213 (2006).
21. Date AA. Colloidal carriers for improved drug delivery. A thesis submitted to University of Mumbai, Mumbai, India, March 2010.
22. Sanghvi R, Narazaki R, Machatha SG, Yalkowsky SH. Solubility improvement of drugs using N-methyl pyrrolidone. AAPS PharmSciTech. 9, 366-376 (2008).
23. Jain P, Yalkowsky SH. Solubilization of poorly soluble compounds using 2-pyrrolidone. Int. J. Pharm. 342, 1-5 (2007).
24. Date AA, Patravale VB. Microemulsions: applications in transdermal and dermal delivery. Crit. Rev. Ther. Drug Carrier Syst. 24, 547-596 (2007).
25. Aparicio RM, José Garca-Celma M, Pilar Vinardell M, Mitjans M. In vitro studies of the hemolytic activity of microemulsions in human erythrocytes. J. Pharm. Biomed. Anal. 39, 1063-1067 (2005).
26. Sitarek K, Stetkiewicz J. Assessment of reproductive toxicity and gonadotoxic potential of N-methyl-2-pyrrolidone in male rats. Int. J. Occup. Med. Environ. Health 21, 73-80 (2008).
27. Flick B, Talsness CE, Jckh R, Buesen R, Klug S. Embryotoxic potential of N-methyl-pyrrolidone (NMP) and three of its metabolites using the rat whole embryo culture system. Toxicol. Appl. Pharmacol. 237, 154-167 (2009).
28. Date AA, Nagarsenker MS. Parenteral microemulsions: an overview. Int. J. Pharm. 355, 19-30 (2008).
29. Drogoz A, David L, Rochas C, Domard A, Delair T. Polyelectrolyte complexes from polysaccharides: formation and stoichiometry monitoring. Langmuir 23, 10950-10958 (2007).
30. Peetla C, Labhasetwar V. Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake. Langmuir 25, 2369-2377 (2009).
31. Galindo-Rodriguez S, Allémann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm. Res. 21, 1428-1439. (2004).
32. Hansen CM. Hansen Solubility Parameters: A Users Handbook, 2nd Edition. CRC Press, FL, USA, 280-284 (2007).
33. Adamska K, Voelkel A, Héberger K. Selection of solubility parameters for characterization of pharmaceutical excipients. J. Chromatogr. A 1171, 90-97 (2007).
34. Kacperska A. DSC investigations of DDAB, DTAB and DHAB vesicle aqueous solutions in presence of SDS. J. Thermal. Anal. Cal. 61, 63-73 (2000).
35. Ballerat-Busserolles K, Rassinoux S, Roux-Desgranges G, Roux AH. Thermal analysis of aqueous micellar solutions: study of some structural transitions and of solute-surfactant complexes. J. Thermal. Anal. Cal. 51, 161-171 (1998).
36. Das JR, Bhakoo M, Jones MV, Gilbert P. Changes in the biocide susceptibility of Staphylococcus epidermidis and Escherichia coli cells associated with rapid attachment to plastic surfaces. J. Appl. Microbiol. 84, 852-858 (1998).
37. Schmiedel H, Almsy L, Klose G. Multilamellarity, structure and hydration of extruded POPC vesicles by SANS. Eur. Biophys. J. 35, 181-189 (2006).
38. Grillo I, Penfold J, Tucker I, Cousin F. Spontaneous formation of nanovesicles in mixtures of nonionic and dialkyl chain cationic surfactants studied by surface tension and SANS. Langmuir 25, 3932-3943 (2009).
39. Yue B, Huang CY, Nieh MP, Glinka CJ, Katsaras J. Highly stable phospholipid unilamellar vesicles from spontaneous vesiculation: a DLS and SANS study. J. Phys. Chem. B 109, 609-616 (2005).
40. Aswal VK, Haldar J, De S, Goyald PS, Bhattacharya S. Characterization of vesicles from ion-paired gemini surfactants by small angle neutron scattering. Phys. Chem. Chem. Phys. 5, 907-910 (2003).
41. Chiappetta DA, Degrossi J, Teves S, DAquino M, Bregni C, Sosnik A. Triclosan-loaded poloxamine micelles for enhanced topical antibacterial activity against biofilm. Eur. J. Pharm. Biopharm. 69, 535-545 (2008).
42. Mahmoud SS, Gehman JD, Azzopardi K, Robins-Browne RM, Separovic F. Liposomal phospholipid preparations of chloramphenicol for ophthalmic applications. J. Pharm. Sci. 97, 2691-2701 (2008).
43. Hosny KM. Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin. AAPS PharmSciTech. 10, 1336-1342 (2009).
44. Tabatt K, Sameti M, Olbrich C, Mller RH, Lehr CM. Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer. Eur. J. Pharm. Biopharm. 57, 155-162 (2004).
45. Li P, Zhang L, Ai K, Li D, Liu X, Wang E. Coating didodecyldimethyl- ammonium bromide onto Au nanoparticles increases the stability of its complex with DNA. J. Control. Release 129, 128-134 (2008).
46. Li D, Li G, Li P et al. The enhancement of transfection efficiency of cationic liposomes by didodecyldimethylammonium bromide coated gold nanoparticles. Biomaterials 31, 1850-1857 (2010).